CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities:
Net income (loss)	$ 203,408	$ (222,719)
Reconciliation of net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	6,765	2,317
Non-cash stock-based compensation	32,933	53,060
Right-of-use assets expensed	214	951
Other items, net	634	6,362
Changes in operating assets and liabilities:
Inventory	(99,557)	0
Receivables, prepaid expenses, and other assets	(56,016)	220,205
Accounts payable and accrued expenses	(115,500)	53,325
Deferred revenue	(61,391)	549,584
Net cash provided by (used in) operating activities	(88,510)	663,085
Investing Activities:
Capital expenditures	(16,826)	(13,781)
Purchases of marketable securities	0	(2,167)
Proceeds from maturities and sale of marketable securities	0	157,557
Net cash provided by (used in) investing activities	(16,826)	141,609
Financing Activities:
Net proceeds from sales of common stock	179,385	564,859
Net proceeds from the exercise of stock-based awards	1,318	24,099
Finance lease payments	(20,838)	(11,971)
Net cash provided by financing activities	159,865	576,987
Effect of exchange rate on cash, cash equivalents, and restricted cash	1,312	(1,349)
Net increase in cash, cash equivalents, and restricted cash	55,841	1,380,332
Cash, cash equivalents, and restricted cash at beginning of period	1,528,259	648,738
Cash, cash equivalents, and restricted cash at end of period	1,584,100	2,029,070
Supplemental disclosure of non-cash activities:
Right-of-use assets from new lease agreements	58,352	9,770
Capital expenditures included in accounts payable and accrued expenses	15,874	9,076
Supplemental disclosure of cash flow information:
Cash interest payments	6,654	7,530
Cash paid for income taxes	$ 15,451	$ 3,017